Nathan S. Ivey, Ph.D.
Affiliations: | US FDA |
Area:
neuroinflammation, neurotoxicology, neurological devices, neuroAIDS, meningitis, neuromicrobiomeGoogle:
"Nathan S. Ivey"Mean distance: 26716.5
Parents
Sign in to add mentor| Barnett R. Nathan | research assistant | UVA | |
| W. Michael Scheld | research assistant | UVA | |
| Andrew A. Lackner | grad student | Tulane | |
| Andrew G. MacLean | grad student | 2005-2010 | Tulane |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Renner NA, Ivey NS, Redmann RK, et al. (2011) MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis. Journal of Neurovirology. 17: 146-52 |
| Ivey NS, Renner NA, Moroney-Rasmussen T, et al. (2009) Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization. Journal of Neurovirology. 15: 312-23 |
| Ivey NS, MacLean AG, Lackner AA. (2009) Acquired immunodeficiency syndrome and the blood-brain barrier. Journal of Neurovirology. 15: 111-22 |
| Ivey NS, Martin EN, Scheld WM, et al. (2005) A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat. Journal of Neuroscience Methods. 142: 91-5 |